Centrus Reports Third Quarter 2026 Results

Centrus Energy’s Q3 2026 revenue fell 26% year over year to $55.5 million, and its non-GAAP adjusted net loss was $9.4 million versus adjusted net income of $5.2 million a year earlier; gross loss widened to $10.6 million. GAAP net income rose to $31.6 million from $3.9 million, primarily reflecting a $46.4 million gain from the fair-value adjustment of warrant liabilities. The company reported $7.0 billion in backlog, including $5.4 billion of contingent LEU and HALEU commitments, and expects 2026 revenue of $450 million–$500 million while increasing planned capital deployment to $350 million–$500 million.

Analysis

The headline earnings figure is not a signal of improved operating power: the warrant revaluation drove reported profit while adjusted results remained loss-making. More concerning for the expansion thesis, SWU unit costs rose faster than realized prices this quarter; contract mix can distort any single quarter, but repeated spread compression would undermine the economics of scaling. The LEU segment’s delivery timing makes this a metric to monitor, not yet proof of a structural margin problem.

Execution milestones reduce construction risk, but they do not convert the $5.4B contingent sales commitments into funded demand or demonstrate profitable production. The absence of further proposed FY27 DOE funding for the HALEU operating contract is a separate near-term revenue/margin risk; do not treat the full Technical Solutions backlog as bankable. Centrus also guides to $450–500M of 2026 revenue, implying $142–192M in Q4 after $308M through nine months versus $55.5M in Q3. That unusually high implied step-up makes delivery cadence and contract timing immediate verification points.

Capital availability is less acute after financing, but the build is consuming cash: nine-month capex was $226M, and the company expects $350–500M of full-year capital deployment. Equity/warrant financing also raises dilution and overhang considerations. Over 1–3 months, focus on Q4 delivery confirmation, DOE appropriations, and updated funding/task orders; over 6–18 months, successful commissioning and repeatable unit economics matter more than backlog headlines. The contrarian upside is that domestic enrichment capacity may command strategic value, and early factory milestones can lower execution risk. That upside is not yet evidence of attractive returns on invested capital.

Key Decisions for Investors

• Do not buy the GAAP EPS headline. Underweight or avoid adding to LEU on strength until reported operating performance—not warrant marks—improves.
• Treat any sharp post-release rally as a potential fade, but wait for price/volume behavior and borrow availability before initiating a short; no price target is supportable from the supplied data. Risk to the bearish view: confirmed Q4 deliveries near the implied guidance run rate alongside improving SWU price-cost spreads.
• Set an alert for the next results and DOE budget updates: verify Q4 revenue against the $142–192M implied range, the funding status of the HALEU operating work, and whether SWU realized-price growth catches up with unit-cost growth. Failure on these measures would strengthen the downside case.
• For a 6–18 month thesis, require evidence of commissioning progress, funded rather than contingent customer commitments, and capital deployment translating into operating capacity before assigning substantial value to the backlog.